glp 1 prescribing guidelines Guide for safe, effective GLP-1 prescribing in primary care Ten Top Tips for the
Description
A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss
Track doses of Ozempic(R), Wegovy(R), Wegovy(TM) Pill, Mounjaro(R),...
February 4, 2026: Washington, DC A year ago, theNational Consumers League took the unusual step offlaggingwarningsfromthe Food and Drug Administration(FDA) and medical societiesstatingthatcompounded versions of GLP-1 (glucagon-like peptide-1 receptor agonists)weight-lossdrugs are not FDA approved and may cause serious health problems.The purposewas toinformconsumers aboutthe potential harm posed by these drugsbeforeHims & Hers, a large telehealth company,aired awidely hyped television ad duringthe 2025 Super Bowl touting only the benefitsof compoundedGLP-1s.
Liraglutide (3.0 mg, daily subcutaneous injection, n=22) or semaglutide (1.0 mg, weekly subcutaneous injection, n=18) was started 74.5 (51.0, 108.3) months after surgery following a weight regain of 14.7 (10.3, 19.6)%
Digestive enzymes to calm the gut and ease feelings of nausea
